Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid).

Literature DB >> 25714278

Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid).

Kartik Jhaveri¹, Sean Cleary, Pascale Audet, Fady Balaa, Deepak Bhayana, Kelly Burak, Silvia Chang, Elijah Dixon, Masoom Haider, Michele Molinari, Caroline Reinhold, Morris Sherman.

Abstract

OBJECTIVE. This systematic review presents evidence-based consensus statements as reported by a multidisciplinary expert panel (six abdominal radiologists, four hepatobiliary surgeons, and two hepatologists) regarding the use of gadoxetic acid for liver MRI. CONCULSION. Although this review highlights the incremental diagnostic value of hepatobiliary phase imaging with gadoxetic acid-enhanced liver MRI in multiple clinical scenarios, there remains a need for further impact studies for some clinical applications, such as hepatocellular carcinoma in cirrhosis.

Entities: Chemical Disease

Keywords: Eovist; Gd-EOB-DTPA hepatobiliary; MRI; Primovist; gadoxetate disodium; gadoxetic acid; liver

Mesh：

Substances：

Year: 2015 PMID： 25714278 DOI： 10.2214/AJR.13.12399

Source DB: PubMed Journal: AJR Am J Roentgenol ISSN： 0361-803X Impact factor: 3.959

Keyword Cloud
Cited

23 in total

1. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors: Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal: J Nucl Med Date: 2015-10-15 Impact factor: 10.057

Review 2. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors: Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal: Abdom Radiol (NY) Date: 2017-08

Review 3. Gd-EOB-DTP-enhanced MRC in the preoperative percutaneous management of intra and extrahepatic biliary leakages: does it matter?

Authors: Mario Petrillo; Anna Maria Ierardi; Laura Tofanelli; Duilia Maresca; Alessio Angileri; Francesca Patella; Gianpaolo Carrafiello
Journal: Gland Surg Date: 2019-04

Review 4. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Authors: Arman Sheybani; Ron C Gaba; R Peter Lokken; Senta M Berggruen; Winnie A Mar
Journal: Curr Gastroenterol Rep Date: 2017-10-18

Review 5. Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.

Authors: YoonSeok Choi; Jimi Huh; Dong-Cheol Woo; Kyung Won Kim
Journal: Br J Radiol Date: 2015-12-23 Impact factor: 3.039

6. Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting.

Authors: Kelly Warren Burak; Morris Sherman
Journal: Can J Gastroenterol Hepatol Date: 2015-05

Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid).

1. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Review 2. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Review 3. Gd-EOB-DTP-enhanced MRC in the preoperative percutaneous management of intra and extrahepatic biliary leakages: does it matter?

Review 4. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Review 5. Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.

6. Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting.

Review 7. [Radiological diagnostic workup of liver tumors].

8. Abbreviated Gadoxetic Acid-enhanced MRI with Second-Shot Arterial Phase Imaging for Liver Metastasis Evaluation.

Review 9. Multiparametric MR Imaging in Abdominal Malignancies.

Review 10. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.